MOSCOW: Russia on Saturday approved a third coronavirus vaccine for domestic use, Prime Minister Mikhail Mishustin said on state TV, though large-scale clinical trials of the shot, labelled CoviVac and produced by the Chumakov Centre, have yet to begin.
Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a similar approach of granting approval before seeing any late-stage trial results.
The preemptive approvals had raised concerns among some scientists in the West, but inoculations with those first two shots began on a mass scale in Russia only after trials were concluded and showed success.
Sputnik V was approved in August and late-stage trials began in September. Mass vaccination was launched in December, after preliminary trial results showed the vaccine to be 91.4% effective.
Since then, more than two million Russians have been vaccinated with at least the first dose of Sputnik V, Health Minister Mikhail Murashko said on Feb. 10.
Rollout of a second vaccine, developed by the Vector Institute in Novosibirsk, is beginning.
"Today, Russia is the only country to have already three vaccines against COVID-19," Prime Minister Mishustin said.
The Chumakov Centre, founded in 1955 in St Petersburg by Mikhail Chumakov, is known for its work with U.S. scientist Albert Sabin at the height of the Cold War, which led to the production of the widely-used polio vaccine.
DIFFERENT TYPE OF VACCINE
Unlike the Sputnik V vaccine, which uses a modified harmless cold virus that tricks the body into producing antigens to help the immune system prepare for a coronavirus infection, the CoviVac vaccine is a "whole-virion" vaccine.
This means it is made of a coronavirus that has been inactivated, or stripped of its ability to replicate.
"The vaccine we have developed... reflects the whole history of Russian, as well as global, vaccine science," the Chumakov Centre's director, Aidar Ishmukhametov, said on Saturday.
The advantage, according to virologist Alexander Chepurnov, cited by outlet Lenta.Ru, is that CoviVac includes all elements of the virus, creating a broader immune response that is likely to protect against any variants.
However, testing Russia's COVID-19 shots against SARS-CoV-2 variants that have emerged in the UK, South Africa and elsewhere is in its early stages. President Vladimir Putin on Monday ordered a review of Russia's COVID-19 vaccines to be presented by March 15 assessing their ability to protect against the new variants.
RESULTS SO FAR
Globally, one other major vaccine candidate - India's COVAXIN by Bharat Biotech - uses the "whole-virion" approach.
India's drug regulator has touted the shot's ability to act against the whole body of a virus instead of just its "spike-protein" tip, potentially making it more effective in case of mutations.
The CoviVac shot is given in two doses, 14 days apart. It is transported and stored at normal fridge temperatures, of 2 to 8 degrees Celsius (35.6 to 46.4 Fahrenheit), Deputy Prime Minister Tatiana Golikova said in a government briefing in January.
The shot has already been tested for safety on 200 people aged between 18 and 60, Ishmukhametov told the state-run Vesti-24 news channel in late January.
This early-stage trial began on Sept. 21 last year, according to the state clinical trials register. It showed no side-effects, including no rise in temperature, Ishmukhametov said.
Mid-stage trials to test volunteers' immune responses were ongoing, he said at the time.
Only a placebo-controlled, large-scale trial could ascertain effectiveness, he added. This is due to begin now that the go-ahead has been granted.
The first 120,000 doses, however, will be produced and released to the national inoculation programme in March, Mishustin said.
Then, the Chumakov Centre will produce around half a million doses per month on its platforms, Ishmukhametov said on Saturday.
Deputy Prime Minister Golikova also announced on Saturday that Russia will produce 88 million vaccine doses in the first half of this year, including 83 million Sputnik V doses.
Reuters
Sat Feb 20 2021
Russian Prime Minister Mikhail Mishustin chairs a meeting with senior executives of the Central Office of Russian Government in Moscow, Russia, Jan 19, 2021. REUTERSpic
Pegawai, anggota bomba di lima negeri ada masalah kesihatan
Ujian Kemahiran Taktikal Kebombaan diduduki seramai 12,608 anggota dan pegawai dan hanya 9,313 sahaja yang lulus.
Kerajaan komited lahirkan lebih ramai teknousahawan
Anugerah Teknousahawan TVET@KKDW diperkenalkan bagi memberi pengiktirafan serta penghargaan kepada institusi, pengajar, pelajar, graduan dan alumni yang telah menunjukkan kecemerlangan dalam bidang keusahawanan TVET.
Kedah bakal bangunkan LRT di Langkawi
Kedah merancang membina sistem tren Transit Aliran Ringan (LRT) menggunakan teknologi levitasi magnet di Langkawi
Kes pedofilia MRSM Tumpat diklasifikasikan fitnah, tiada bukti kukuh
Kes pedofilia terhadap seorang guru Maktab Rendah Sains Mara di Tumpat diklasifikasikan sebagai fitnah selepas siasatan tidak menemui bukti kukuh berhubung kes itu, kata Ketua Polis Kelantan Datuk Muhamad Zaki Harun.
Kerajaan berusaha tangani inflasi, tingkat kuasa beli rakyat
Menurut Datuk Armizan Mohd Ali, kerajaan tidak berdiam diri dalam menangani masalah inflasi termasuk melalui pelaksanaan pelbagai bentuk intervensi seperti kawalan harga.
Keutamaan negara Asia Barat untuk penuhi hasrat rakyat Palestin
Sekiranya Palestin diberikan negara dan kebebasan, mana-mana pihak tidak perlu lagi campur tangan dan tidak ada lagi konflik di Timur Tengah.
WEF gemakan wawasan, keterbukaan Malaysia dalam tiga hasrat
Mesyuarat Khas Forum Ekonomi Dunia (WEF) menjadi platform untuk Malaysia menggemakan keterbukaan jalinan kerjasama untuk melonjakkan ekonomi negara.
Hari ketiga lawatan Perdana Menteri, Datuk Seri Anwar Ibrahim di Riyadh Arab Saudi membawa wawasan Malaysia memperkasa hubungan bilateral antara negara, selain perbincangan mengenai pelaburan dan usaha memperkasa jalinan kerjasama sedia ada.
Hari ketiga lawatan Perdana Menteri, Datuk Seri Anwar Ibrahim di Riyadh Arab Saudi membawa wawasan Malaysia memperkasa hubungan bilateral antara negara, selain perbincangan mengenai pelaburan dan usaha memperkasa jalinan kerjasama sedia ada.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah yang paling menjadi tumpuan sepanjang hari ini.
Berita tempatan pilihan sepanjang hari ini
Berikut adalah berita yang paling menjadi tumpuan sepanjang Isnin, 29 April 2024.
WEF gemakan wawasan, keterbukaan Malaysia melalui tiga hasrat
Malaysia mahu perkasa hubungan bilateral antara negara, selain perbincangan mengenai pelaburan dan usaha mengukuhkan jalinan kerjasama sedia ada.
13 maut, puluhan cedera ditembak secara rambang di sekolah
Suspek yang menggunakan dua pucuk pistol itu juga dilaporkan membunuh diri selepas melepaskan tembakan secara rambang.
Krisis Ukraine-Rusia: Apa punca sebenar?
Prof Mizan berpendapat, ketegangan antara dua negara itu boleh dikurangkan sekiranya Ukraine menangguhkan hasratnya menyertai NATO.
Krisis Rusia-Ukraine: Macron adakan pertemuan dengan Putin
Pemimpin Perancis itu berkata menyasarkan untuk "berdialog dengan Rusia dan mengurangkan ketegangan" melalui rundingan itu.
Rusia arah jet pejuang iringi pesawat peninjau AS di Laut Hitam
Hubungan dua hala antara AS dan Russia berada pada tahap terendah sejak Kesatuan Soviet berpecah pada 1991.
COVID-19: Kes positif cecah 202 juta dengan 4.2 juta kematian
Kes positif kini meningkat kepada 202 juta, dengan Amerika Syarikat kekal negara paling terjejas dengan lebih 35.7 juta kes.
Olimpik Tokyo: Syaqiera Mashayikh pamer panahan cemerlang sebelum tewas
Pemanah muda negara, Syaqiera Mashayikh, mempamerkan panahan cemerlang sebelum tewas 4-6 kepada peserta dari Jawatankuasa Olimpik Russia, Elena Osipova, dalam pusingan 32 acara recurve individu.
Pesawat Rusia bawa 28 penumpang dilaporkan hilang
Sebuah pesawat AN-26 Russia dengan 28 orang penumpang dilaporkan hilang di semenanjung Kamchatka di timur Russia, kata pihak berkuasa hari ini.
Menuju puncak! Sara Sofea yang pernah tawan Gunung Elbrus raih 9A SPM
Ternyata penglibatan dalam aktiviti sukan lasak tidak menghalang remaja berusia 18 tahun ini mencatat keputusan cemerlang 9A dalam peperiksaan Sijil Pelajaran Malaysia (SPM), baru-baru ini.
COVID-19: Kes jangkitan melebihi 141 juta, korban lebih 3 juta
Angka kes positif kini meningkat kepada 141.01 juta, dengan Amerika Syarikat kekal negara paling terjejas dengan lebih 31.6 juta kes.
Tahniah! Filem 'Belaban Hidup: Infeksi Zombie' muncul filem terbaik festival filem di Rusia
Filem indie, 'Belaban Hidup: Infeksi Zombie' memenangi kategori Filem Terbaik dan Filem Seram Terbaik di International Symbolic Art Film Festival (ISAFF) di St Petersburg, Rusia.